Trial · NCT05717335
Observational Pilot Study With TachoSil as a Ventricular Sealant
NCT05717335, Completed, Germans Trias i Pujol Hospital
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Observational Pilot Study With TachoSil as a Ventricular Sealant. Trials, record NCT05717335. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05717335
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Observational Pilot Study With TachoSil as a Ventricular Sealant
- NCT number
- NCT05717335
- Status
- Completed
- Enrollment
- 20 participants, actual
- Lead sponsor
- Germans Trias i Pujol Hospital
- Conditions
- Intraventricular Neoplasm
- Interventions
- TachoSil
- First posted
- 2023-02-08
- Last updated
- 2023-02-08
Source ClinicalTrials.gov
Registered outcomes2
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | The main objective of the study is to evaluate the effectiveness and safety of TachoSil in operated patients who require opening of the ventricle. | Up to 90 days after surgery | To evaluate the effectiveness and the percentage of complications related to the ventricular entry during surgery. Taking into account hydrocephalus, CSF leak, meningitis and pseudomeningocele. |
| Secondary | Incidence of percutaneous CSF leakage / pseudomeningocele/ hydrocephalus/meningitis | Up to 90 days after surgery | Percentage of complications with percutaneous CSF leakage pseudomeningocele/ hydrocephalus/meningitis |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers17
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT05717335
GET https://conductscience.org/api/trials/v1/NCT05717335/registered